Parkinson
71
9
10
35
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.8%
2 terminated out of 71 trials
94.6%
+8.0% vs benchmark
6%
4 trials in Phase 3/4
20%
7 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 35 completed trials
Clinical Trials (71)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Neuroplasticity in Parkinson's Disease
Driving Performance in Parkinson's Disease and Multiple Sclerosis Using a Driving Simulator
The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
tDCS of the Primary Motor Cortex to Improve Implicit Motor Sequence Learning in Parkinson's Disease
Effects of Transcranial Pulse Stimulation in Parkinson's Disease
Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers
Impact of Exercise on Muscle Metabolism and Function for Persons With Parkinsons
Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment
Neurologic Stem Cell Treatment Study
Electrophysiological Activity of the Subthalamic Nucleus During the Processing of Emotional and Motivational Information
Study of the Efficacy of N-acetylcysteine (NAC) on Impulse Control Disorders
Results of Combined Medical and Swallowing Behavioral Readjustment Therapy in Oropharyngeal Dysphagia Management Among Parkinson's Patients
Studies of Brain and Body Interaction
The Brain&Senses Study
Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's Disease
Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming
Effects of Otago and Frenkel's Exercises on Strengthening of Antigravity Muscles in Parkinson's Disease.